Annotation Detail for C1orf52
Basic Information Top
| Gene Symbol: | C1orf52 ( FLJ44982,RP11-234D19.1,gm117 ) |
|---|---|
| Gene Full Name: | chromosome 1 open reading frame 52 |
| Band: | 1p22.3 |
| Quick Links | Entrez ID:148423; OMIM: NA; Uniprot ID:CA052_HUMAN; ENSEMBL ID: ENSG00000162642; HGNC ID: 24871 |
| Relate to Another Database: | SFARIGene; denovo-db |
Related Pathway Information| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| D016572 | Cyclosporine | Cyclosporine results in increased expression of C1ORF52 mRNA | increases expression | 20106945 |
| D013467 | Sulindac | Sulindac results in increased expression of C1ORF52 mRNA | increases expression | 11906190 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 6.57 | 14745880 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 4.86 | 7897758 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 3.20 | 11910360 | |
| MESH:D000236 | Adenoma | Sulindac | 4.03 | 10223192 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 5.10 | 11874996 11535846 16460482 15623613 19003578 12394442 17611924 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 6.42 | 11207687 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 3.11 | 16642371 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 2.85 | 12371664 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 3.28 | 19486331 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 2.98 | 12902858 12458338 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 2.69 | 10666051 11076880 18059344 11197048 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 5.85 | 17621415 12861449 | |
| MESH:D004715 | Endometriosis | Sulindac | 4.98 | 15652904 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 3.22 | 12235107 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 3.40 | 19224547 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 6.36 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 6.02 | 19069698 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 3.90 | 12639820 12168785 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 5.69 | 11910360 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 5.11 | 8708960 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 5.31 | 15720958 | |
| MESH:D006973 | Hypertension | Cyclosporine | 2.24 | 10903974 | |
| MESH:D007249 | Inflammation | Sulindac | 3.52 | 3291741 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 5.14 | 12351151 10213222 12628509 10223192 12584176 12663524 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 5.59 | 12394442 11245490 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 5.51 | 15604871 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 2.58 | 8314463 10903974 18776723 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 3.17 | 12371664 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 4.50 | 12468960 | |
| MESH:D008107 | Liver Diseases | Sulindac | 3.11 | 16867024 14986274 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 2.70 | 15713900 19359593 | |
| MESH:D008545 | Melanoma | Sulindac | 2.88 | 16642371 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 5.86 | 16801185 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 5.51 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 3.75 | 18481113 19348381 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 4.70 | 17266991 16850258 | |
| MESH:D010146 | Pain | Sulindac | 4.22 | 3291741 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 3.48 | 11504793 16820089 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 3.69 | 12371664 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 2.35 | 16882103 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 5.27 | 18645019 | |
| MESH:D014605 | Uveitis | Cyclosporine | 5.05 | 1336536 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 5.51 | 17120751 |
| No data |